Analysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approach

scientific article

Analysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approach is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1051/MEDSCI/20143005020
P9108Erudit article ID20143005020
P698PubMed publication ID24939544
P5875ResearchGate publication ID263205378

P50authorSerge RocheQ86002755
P2093author name stringSerge Urbach
Audrey Sirvent
P2860cites workImmunoaffinity profiling of tyrosine phosphorylation in cancer cellsQ21735929
The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factorsQ24304594
Systematic and quantitative assessment of the ubiquitin-modified proteomeQ24634631
Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortexQ24674103
Protein modules and signalling networksQ27860694
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomicsQ28131742
Oncogenic kinase signallingQ28189493
Mass spectrometry-based proteomics turns quantitativeQ28291379
'Srcasm: a novel Src activating and signaling moleculeQ28505622
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationQ29547200
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagentsQ29547450
Transforming gene product of Rous sarcoma virus phosphorylates tyrosineQ29620005
The greater RTK/RAS/ERK signalling pathway: how genetics has helped piece together a signalling networkQ33350367
Role of Src expression and activation in human cancerQ34103650
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemiaQ34622576
The interplay between Src family kinases and receptor tyrosine kinasesQ35920901
Signaling networks assembled by oncogenic EGFR and c-MetQ36392991
Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenograftsQ36455713
Analytical strategies for phosphoproteomicsQ37398801
The long road to colorectal cancer therapy: searching for the right signalsQ37696803
Technologies and challenges in large-scale phosphoproteomicsQ38081123
Super-SILAC mix for quantitative proteomics of human tumor tissueQ39719028
Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cellsQ39874657
Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cellsQ40252758
Stable-isotope dimethyl labeling for quantitative proteomicsQ40608471
Phosphotyrosine Signaling: Evolving a New Cellular Communication SystemQ42413402
SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell functionQ46458771
[The tumoral microenvironment: feeding resources, battle field and therapeutic target in cancer].Q50850027
Tyrosine kinases as targets for cancer therapyQ80367757
Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalizationQ82244718
[Quantitative proteomics by SILAC: practicalities and perspectives for an evolving approach]Q84767885
[Emerging notions about the microenvironmental control of tumor growth and dissemination]Q87820272
P433issue5
P304page(s)558-566
P577publication date2014-05-01
P1433published inmédecine/sciencesQ3332441
P1476titleAnalysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approach
P478volume30

Search more.